Abstract
Among the rare diseases, mucopolysaccharidoses I and II (MPS I and II) are particularly common in the states of São Paulo and Rio Grande do Sul and are caused by mutations in genes encoding lysosomal proteins (enzymes). The currently available treatments are not curative and are particularly inefficient for the prevention of neurological symptoms. In addition, they cost millions of dollar…